GBI: Manufacturing of Biologics on reports-research.com

GBI Research's report, Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies, provides the key data and analyzes the major challenges and drivers for the bio-manufacturing industry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the manufacturing of biologics. The report also discusses the key market drivers and barriers for the growth of bio-manufacturing in the pharmaceutical and biotech industry. The report is based on proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts to provide a comprehensive view of the manufacturing of biologics.

The Global Biologics Industry Has Grown More Rapidly Than the Global Pharmaceutical Industry

The biologics industry has emerged as a major growth area in the global healthcare industry. Since its emergence in the 1970s, the biologics industry has grown rapidly to reach approximately $128 billion in 2009. GBI Research’s analysis suggests that the biologics drugs market has outperformed the pharmaceutical market in the past few years. The biologics industry had a year on year average growth rate of approximately 11.5% over the period of 2007–2009. This is significantly higher than the pharmaceutical industry’s growth rate of 6% in the same time period. It is expected to grow by 9.3% for the period of 2009–2016.

Strong Growth is expected in the CMO Biologics Market

The use of CMOs is one of the most significant trends in the healthcare industry, especially in the biologics market. CMOs will be used for most of the processes in the industry. Although the CMO market is not growing much at the moment due to capacity expansions by major companies such as Lonza Group Ltd., Boehringer Ingelheim (BI), and many more. Their focus has been shifted towards setting up new plants, buying new equipments. These expansion processes indicate the future prospects of the industry. Many experts in the industry have already predicted that the future of the CMO market is bright. Several players from emerging countries are entering the market. Companies are opening up beginning operations in emerging countries such as India, China, and Singapore.

GBI Research suggests that the CMO biologics market is set to grow at a CAGR of 13.4%, (2009-16) which is faster than the overall CMO market.

The market shares of CMOs the developed countries are expected to decline in the coming years due to the high cost of operations and due to the development taking place in the emerging markets. The share of the emerging markets is expected to more than double by 2013 and to triple by 2016.

Biologics Manufacturing Capacity and Production

Biologics manufacturing is expected to grow in the near future. Most of the biologics companies are expanding their manufacturing facilities throughout the world. New companies are coming into the market and many pharmaceutical companies are now manufacturing biologics.

Currently, the capacity in the industry is more than the production. The major reasons for this are the low capacity utilization rate and low demand.

GBI Research expects the overall capacity to grow at 10.8% from 2009 to 2013, after which market will stabilize and growth rate will be slower. It is expected that it will be grow at the rate of 1.42% over the period of 2013-2016.

GBI: Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies:
http://www.reports-research.com/market-surveys/manufacturing-biologics-increasing-demand-monoclonal-antibodies-recombinant-proteins-drives-increases-capacities-innovative-production-technologies-p-123957.html

GBI: More market data and market reports:
http://www.reports-research.com/market-surveys/gbi-research-m-348.html

markt-studie.de, founded in 2002 has emerged as a leading online portal for market surveys and market research in German speaking areas. Four years later the English language portal reports-research.com was introduced due to the extraordinary success of the portal. Again one year later estudio-mercado.es - the Spanish spoken portal - was founded. The objective of the three portals is to competently and efficiently support consultants and decision makers in management, sales and marketing in the search for worldwide market research. Prospective buyers can look into more than 60,000 market surveys from more than 200 international publishers, current market data for more than 6,000 branches worldwide, 10,000 company profiles as well as a free-of-charge research and recommendation service for individual market research.

reports-research.com
c/o dynamic technologies GmbH
Siegburger Str. 233
50679 Köln
Germany

Manuel Bravo Sanchez (CEO)

info@reports-research.com
or
Tel ++49 (0)221 677 897 32
Fax ++49 (0)221 677 897 34

This release was published on openPR.